Andrew A. Hindman, Chief Business Development Officer at ACORDA THERAPEUTICS INC (ACOR), sold 4,779 shares at $30.16 ($142K) on 2015-05-15, disclosed to the SEC on 2015-05-15.
Scheduled sale ($142k) by Chief Business Development Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $29.78 | 4,304 | $128K | 89.9% |
| 2 | $30.16 | 475 | $14K | 10.1% |
| Total | $29.82 avg | 4,779 | $142K | 100% |
| Filing → |
| ACOR | SELL | 2018-05-30 | $2.1M | — | Filing → |
| ACOR | SELL | 2017-12-05 | $17K | — | Filing → |
| ACOR | SELL | 2017-05-17 | $121K | — | Filing → |